Drosophila CYP6g1 and its human homolog CYP3A4 confer tolerance to methylmercury during development.
Methylmercury (MeHg) is a persistent environmental toxicant that is commonly encountered through dietary fish and seafood. While the fetal nervous system is a well-known primary target for MeHg toxicity, the risks of MeHg exposures that are commonly experienced today through diet and environmental exposure remain uncertain. Despite knowledge of numerous cellular processes that are affected by MeHg, the mechanisms that ultimately influence tolerance or susceptibility to MeHg in the developing fetus are not well understood. Using transcriptomic analyses of developing brains of MeHg tolerant and susceptible strains of Drosophila, we previously identified members of the cytochrome p450 (CYP) family of monooxygenases/oxidoreductases as candidate MeHg tolerance genes. While CYP genes encode Phase I enzymes best known for xenobiotic metabolism in the liver, several classes of CYPs are required for synthesis or degradation of essential endobiotics, such as hormones and fatty acids, that are critical to normal development. We now demonstrate that variation in expression CYP genes can strongly influence MeHg tolerance in the developing fly. Importantly, modulating expression of a single CYP, CYP6g1, specifically in neurons or the fat body (liver equivalent) is sufficient to rescue development in the presence of MeHg. We also demonstrate a conserved function for CYP3A4, a human homolog of CYP6g1, in conferring MeHg tolerance to flies. Finally, we show that pharmacological induction of CYPs with caffeine parallels an increase in tolerance to MeHg in developing flies. These findings establish a previously unidentified role for CYPs in MeHg toxicity and point to a potentially conserved role of CYP genes to influence susceptibility to MeHg toxicity across species.
Department of Anatomy and Neurobiology, College of Medicine, University of Vermont, Burlington, VT 05405, USA. matthew.rand@uvm.edu
Matthew D
MD
Rand
Jessica A
JA
Lowe
Cecon T
CT
Mahapatra
D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics / Q000254:growth & development; D017124:Conserved Sequence / Q000235:genetics; D051544:Cytochrome P-450 CYP3A / Q000235:genetics*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D029721:Drosophila Proteins / Q000235:genetics*; D004331:Drosophila melanogaster / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D004361:Drug Tolerance / Q000235:genetics; D020869:Gene Expression Profiling; D008767:Methylmercury Compounds / Q000009:adverse effects*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012689:Sequence Homology, Nucleic Acid
D029721:Drosophila Proteins; D008767:Methylmercury Compounds; D003577:Cytochrome P-450 Enzyme System; C446928:Cyp6g1 protein, Drosophila; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human